Dr. Homeira Mehrabian, MD

Dr. Mehrabian practices at Newport Beach Orange Coast Endoscopy Center in Newport Beach, California.

Dr. Mehrabian's NPI, 1699972844, was assigned on June 29, 2007. Dr. Mehrabian graduated from UTMB Health in 1991. Dr. Mehrabian holds California license A53225.

Dr. Mehrabian's primary practice is Newport Beach Orange Coast Endoscopy Center, at 1525 Superior Ave, Ste 114, Newport Beach, CA 92663. The practice phone is (949) 646-6999.

Dr. Mehrabian's primary practice is Newport Beach Orange Coast Endoscopy Center in Newport Beach, California. Dr. Mehrabian is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Homeira Mehrabian, MD Inc. Dmand AI also links Dr. Mehrabian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehrabian practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mehrabian's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mehrabian is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mehrabian's licenses on file in 2 states: California and Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic anemia, chronic hypertension, chronic inflammatory bowel disease (IBD), fatty liver, gastroduodenitis and gastrointestinal bleeding among the conditions Dr. Mehrabian treats.

CMS data shows 1,172 Medicare services from Dr. Mehrabian across 11 procedure codes in 2024, for 475 Medicare patients. Medicare paid $113,940 for them.

CMS counts 475 Medicare patients who saw Dr. Mehrabian in 2024. The largest group is 65 to 74, with 229 patients. 75% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehrabian's median patient age at 63, with 78% women.

In 2024, Dr. Mehrabian wrote 2,046 Medicare Part D claims for 443 patients. 93% of them were for generic drugs. CMS names the drug for 1,984 of them, across 16 drugs with 11 or more claims each, at $143,999 in total drug cost. In 2023, CMS named 1,783 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mehrabian for performance year 2024, reported individually. Dr. Mehrabian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehrabian as offering telehealth. CMS counts 220 procedures of colonoscopy by Dr. Mehrabian, more than 95% of the clinicians it reports for that procedure.

CMS Open Payments shows 412 general payments to Dr. Mehrabian from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,055.

Dmand AI lists 1 award for Dr. Mehrabian, most recently CMS Stage 1 EHR in 2013.

Dr. Mehrabian graduated from UTMB Health in 1991.

Dr. Mehrabian is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.